Skip to main content
. 2018 Oct 24;30:91–104. doi: 10.1016/j.ddtec.2018.10.002

Fig. 4.

Fig. 4

New conjugation technology that enables disulfide rebridging includes derivatives based on (a) bissulfone, (b) dibromoalkyl oxetane, (c) dibromopyridazinediones and (d) dibromo/dithiophenyl maleimides. This technology has not been applied to radionuclide-labelling of antibodies, but is a promising future avenue.